Logo for LaunchBio Program: WebinarsLogo for LaunchBio Program: Webinars

Connecting biotech entrepreneurs, industry, and researchers with knowledge, captial, and talent

  • October 3, 2024
  • 10am PT / 1pm ET
Online

Lean into Success

Smart Financial Moves for Thriving Startups

Program


In today’s cash-tight fundraising market, running a lean operation and strategically using funds is more important than ever. Efficient budget management is critical for early-stage founders to reach early milestones and secure their next round of funding.

Join us for an expert-led webinar featuring top industry leaders who will share success stories and actionable strategies to help you extend your cash runway and maximize human, capital and financial resources. Learn how to creatively allocate funds, negotiate better deals and make smarter decisions to keep your company thriving without compromising growth and innovation.

Speakers

  • Stephen Perry, Founder and CEO, Kymanox

    Stephen Perry, Founder and CEO, Kymanox

    Stephen M. Perry is the CEO and Founder of Kymanox—a diversified and global professional services company solely focused on the Pharmaceutical, Biotechnology, Medical Device, and Combination Product industries. He has extensive CGxP experience as a Process Engineer, Technical Project Manager, Quality Auditor, and Regulatory Strategist. As a business executive, Stephen has successfully attracted growth capital from WestView Capital Partners and has further grown the unique Kymanox platform with the acquisition of four different companies.

  • Tyler Mizenko

    Tyler Mizenko, MBA, Chief Revenue Officer, Prendio-BioProcure

    Tyler Mizenko is the Chief Revenue Officer at Prendio-BioProcure, where he leads the go-to-market strategy and oversees the company’s global sales efforts, alliances, and partnerships. Tyler has played a pivotal role in building and scaling Prendio-BioProcure sales strategy and execution while providing crucial support to the executive leadership team. He has been instrumental in negotiating and executing partnerships with leading global life science suppliers and the Venture Capital firms that Prendio-BioProcure collaborates with today.

  • Marguerite Hutchinson, J.D.

    Marguerite Hutchinson, JD, Chief Business Officer, Storm Therapeutics

    Marguerite Hutchinson has over 15 years of experience leading collaboration efforts in the biotech and pharmaceutical industry, providing business development and legal guidance to R&D teams creating treatments for cancer. She is currently Chief Business Officer at Storm Therapeutics, and has held other C-level roles at a seed-funded academic spinout, Frontier Medicines, and Plexxikon Inc. Marguerite has been recognized as one of the Top 25 Women Leaders in Biotech by the Healthcare Technology Report.

Tags